Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

APOTEX INC

  • FDA Approval
  • April 24, 2025, 08:49 UTC
  • 60
  • 0 comments

FDA approve AXITINIB

Comment Full text

AUROBINDO PHARMA LTD

  • FDA Approval
  • April 24, 2025, 08:49 UTC
  • 59
  • 0 comments

FDA approve ZIDOVUDINE

Comment Full text

HERITAGE

  • FDA Approval
  • April 24, 2025, 08:49 UTC
  • 61
  • 0 comments

FDA approve HYDRALAZINE HYDROCHLORIDE

Comment Full text

MIRUM

  • FDA Approval
  • April 21, 2025, 14:42 UTC
  • 71
  • 0 comments

FDA approve MARALIXIBAT

Comment Full text

Premier Research Consulting, LLC

  • FDA Approval
  • April 21, 2025, 14:28 UTC
  • 71
  • 0 comments

FDA approve ARIPIPRAZOLE

Comment Full text

AUROBINDO PHARMA LTD

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 49
  • 0 comments

FDA approve FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE

Comment Full text

JANSSEN BIOTECH

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 49
  • 0 comments

FDA approve GOLIMUMAB

Comment Full text

JUBILANT GENERICS

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 55
  • 0 comments

FDA approve OLMESARTAN MEDOXOMIL

Comment Full text

SCIEGEN PHARMS INC

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 41
  • 0 comments

FDA approve BUPROPION HYDROCHLORIDE

Comment Full text

BRISTOL MYERS SQUIBB

  • FDA Approval
  • April 21, 2025, 08:45 UTC
  • 59
  • 0 comments

FDA approve APIXABAN

Comment Full text
  • Previous
  • 195
  • 196
  • 197
  • 198
  • 199
  • Next

Search

News categories

  • Technical Exchange News(12263)
  • Event(6229)
  • SEC News(267570)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(155696)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin